Viewing nowWinrica Capsule 75 mg (Pregabalin)
Pregabalin 75mg
Hard capsule · Prescription medication
Hanwha Pharmaceutical Co., Ltd.

MFDS item code 201800768 · Approved 2018.02.09 · Insurance code 651602340
Treatment of peripheral and central neuropathic pain, adjunctive treatment for partial seizures in epilepsy, alleviation of fibromyalgia.
This medication is used for the treatment of pain from peripheral and central neuropathy in adults. Additionally, it is administered as an adjunctive treatment for patients with epilepsy experiencing partial seizures, whether accompanied by secondary generalized symptoms or not. It also helps alleviate pain in patients with fibromyalgia. It is effective in treating a variety of neuro-related symptoms.
This medication is taken orally without regard to meals, divided into two doses per day. 1. Neuropathic Pain - Peripheral neuropathic pain: Initial dose of 150 mg per day, which can be increased to 300 mg per day within 3 to 7 days; if necessary, it can be further increased to a maximum of 600 mg every 7 days. - Central neuropathic pain: Initial dose of 150 mg per day, which can be increased to 300 mg per day after one week.
Not recommended for children under the age of 12 and adolescents aged 12-17 due to lack of safety and efficacy data.
This medication may increase the risk of suicidal thoughts or behavior; therefore, any changes in mood or symptoms of depression during treatment should be reported to medical personnel immediately. Patients with hypersensitivity to this medication should not take it. Patients with diabetes should carefully manage blood sugar levels, as this medication may lead to weight gain and make it difficult to control blood sugar. If symptoms such as swelling around the face or neck and difficulty breathing occur, the medication should be discontinued immediately, and the patient should visit a hospital. Elderly patients may experience increased dizziness or drowsiness from this medication, so caution is advised after taking it, and care should be taken to reduce the risk of falls. If vision becomes blurry or abnormal eye symptoms occur, the medication should be stopped, and a doctor should be consulted. Abruptly discontinuing this medication can cause withdrawal symptoms such as insomnia, headache, and anxiety, so it should be reduced gradually under medical supervision. There is a risk of drug abuse, so patients with a history of mental illness or substance abuse should consult healthcare professionals before taking this medication. Patients with impaired kidney function may require dose adjustments for this medication. Patients with heart conditions should be cautious as this medication may worsen symptoms of congestive heart failure. Care should be taken when this medication is used in combination with other central nervous system depressants or opioid analgesics, as there is an increased risk of respiratory depression. During early pregnancy, there is a risk of fetal malformation; thus, pregnant women should avoid taking this medication, and women of childbearing age should use effective contraceptive methods. Lactating women should carefully consider whether to breastfeed while taking this medication, as it can be transmitted through breast milk and may affect the baby. It is advisable to avoid hazardous activities such as driving or operating machinery until dizziness or drowsiness from this medication has resolved. In case of overdose, symptoms such as mental confusion, severe drowsiness, or seizures may occur; immediate medical attention is required, and treatment such as hemodialysis may be necessary. This medication should be kept out of reach of children and should not be transferred to another container for safety.
Hives, severe swelling (edema), angioedema, facial swelling, swelling around the mouth and upper airways, chest tightness, difficulty breathing, cold sweat, pallor, severe rash with fever, blisters, skin peeling, pain in oral/ocular mucous membranes, severe skin adverse reactions, shortness of breath or difficulty breathing, asthma attacks, respiratory issues accompanied by cough and fever, jaundice, liver dysfunction, sudden and severe headaches, thunderclap headache, seizures, loss of consciousness.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to prevent exposure to air or moisture. Additionally, it is important to store it in a cool place at a temperature between 15 and 30 degrees Celsius to maintain its efficacy.
A hard capsule with a reddish-brown upper part and a white lower part containing white powder.
30 capsules/bottle, 100 capsules/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowPregabalin 75mg
Hard capsule · Prescription medication
Hanwha Pharmaceutical Co., Ltd.

Pregabalin 75mg
Hard capsule · Prescription medication
Viatris Korea Co., Ltd.

Pregabalin 150mg
Hard capsule · Prescription medication
Viatris Korea Co., Ltd.

Pregabalin 300mg
Hard capsule · Prescription medication
Viatris Korea Co., Ltd.

Pregabalin 150mg
Hard capsule · Prescription medication
Samjin Pharmaceutical Co., Ltd.

Pregabalin 75mg
Hard capsule · Prescription medication
Samjin Pharmaceutical Co., Ltd.

Pregabalin 75mg
Hard capsule · Prescription medication
Hanmi Pharm. Co., Ltd.

Pregabalin 150mg
Hard capsule · Prescription medication
Hanmi Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.